Glucotrack stockholders approve ELOC and bridge note share issuances

Glucotrack, Inc.

Special meeting Sep 11, 2026: quorum 3,661,960 shares (34.61% of 10,578,822 outstanding).
Proposal 1 (ELOC with White Lion Capital): 3,101,374 for, 228,374 against, 332,212 abstentions — approved.
Proposal 2 (Bridge Notes/Warrants): 3,106,894 for, 226,850 against, 328,216 abstentions — approved.
Adjournment proposal not presented because Proposals 1 and 2 passed.
Sep 14, 2026 amendment to Common Warrants requires stockholder approval before exercise per Nasdaq Listing Rule 5635(d).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.